Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is a GLP-1 receptor agonist that works primarily on metabolic pathways rather than immune function
Sadeghi, M
Pain may begin after tooth extraction, root canal treatment, implants, local infection, prolonged jaw opening, or trauma to a small nerve branch
Quick Answer: Semaglutide works by activating GLP-1 receptors throughout the body to enhance glucose-dependent insulin secretion, suppress glucagon release, reduce appetite through central nervous system pathways, and delay gastric emptying
For most patients, the practical scenario involves carrying a single dose or a week's supply during travel or daily activities
This is why preserving muscle mass during weight loss is an important clinical consideration for anyone undertaking significant weight reduction, including those using GLP-1 medications